These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7924138)

  • 41. Type I osteogenesis imperfecta: a nonfunctional allele for pro alpha 1 (I) chains of type I procollagen.
    Barsh GS; David KE; Byers PH
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3838-42. PubMed ID: 6954526
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta.
    Wenstrup RJ; Willing MC; Starman BJ; Byers PH
    Am J Hum Genet; 1990 May; 46(5):975-82. PubMed ID: 2339695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutations in osteogenesis imperfecta leading to the synthesis of abnormal type I procollagens.
    Prockop DJ; Chu ML; de Wet W; Myers JC; Pihlajaniemi T; Ramirez F; Sippola M
    Ann N Y Acad Sci; 1985; 460():289-97. PubMed ID: 3868953
    [No Abstract]   [Full Text] [Related]  

  • 44. Molecular heterogeneity in the mild autosomal dominant forms of osteogenesis imperfecta.
    Tsipouras P; Børresen AL; Dickson LA; Berg K; Prockop DJ; Ramirez F
    Am J Hum Genet; 1984 Nov; 36(6):1172-9. PubMed ID: 6097110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The retention of abnormal type I procollagen and correlated expression of HSP 47 in fibroblasts from a patient with lethal osteogenesis imperfecta.
    Kojima T; Miyaishi O; Saga S; Ishiguro N; Tsutsui Y; Iwata H
    J Pathol; 1998 Feb; 184(2):212-8. PubMed ID: 9602714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BiP binds type I procollagen pro alpha chains with mutations in the carboxyl-terminal propeptide synthesized by cells from patients with osteogenesis imperfecta.
    Chessler SD; Byers PH
    J Biol Chem; 1993 Aug; 268(24):18226-33. PubMed ID: 8349698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduced secretion of structurally abnormal type I procollagen in a form of osteogenesis imperfecta.
    Barsh GS; Byers PH
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5142-6. PubMed ID: 6946461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Osteogenesis imperfecta.
    Byers PH; Steiner RD
    Annu Rev Med; 1992; 43():269-82. PubMed ID: 1580589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Restriction fragment length polymorphism associated with the pro alpha 2(I) gene of human type I procollagen. Application to a family with an autosomal dominant form of osteogenesis imperfecta.
    Tsipouras P; Myers JC; Ramirez F; Prockop DJ
    J Clin Invest; 1983 Oct; 72(4):1262-7. PubMed ID: 6313757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen.
    Deak SB; Nicholls A; Pope FM; Prockop DJ
    J Biol Chem; 1983 Dec; 258(24):15192-7. PubMed ID: 6418743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An ultrastructural, microanalytical, and spectroscopic study of bone from a transgenic mouse with a COL1.A1 pro-alpha-1 mutation.
    Cassella JP; Pereira R; Khillan JS; Prockop DJ; Garrington N; Ali SY
    Bone; 1994; 15(6):611-9. PubMed ID: 7873289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta.
    Nicholls AC; Osse G; Schloon HG; Lenard HG; Deak S; Myers JC; Prockop DJ; Weigel WR; Fryer P; Pope FM
    J Med Genet; 1984 Aug; 21(4):257-62. PubMed ID: 6492090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA polymorphisms in collagen genes: potential use in the study of disease.
    Børresen AL; Berg K; Tsipouras P; Dickson LA; Prockop DJ; Ramirez F
    Prog Clin Biol Res; 1985; 177():37-51. PubMed ID: 2989837
    [No Abstract]   [Full Text] [Related]  

  • 54. Synthesis of a shortened pro-alpha 2(I) chain and decreased synthesis of pro-alpha 2(I) chains in a proband with osteogenesis imperfecta.
    de Wet WJ; Pihlajaniemi T; Myers J; Kelly TE; Prockop DJ
    J Biol Chem; 1983 Jun; 258(12):7721-8. PubMed ID: 6863261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A defect in the structure of type I procollagen in a patient who had osteogenesis imperfecta: excess mannose in the COOH-terminal propeptide.
    Peltonen L; Palotie A; Prockop DJ
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6179-83. PubMed ID: 6934545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutations in type I procollagen genes that cause osteogenesis imperfecta.
    Prockop DJ; Baldwin CT; Constantinou CD
    Adv Hum Genet; 1990; 19():105-32. PubMed ID: 2193488
    [No Abstract]   [Full Text] [Related]  

  • 57. PCR genotyping of oim mutant mice.
    Saban J; King D
    Biotechniques; 1996 Aug; 21(2):190, 192. PubMed ID: 8862795
    [No Abstract]   [Full Text] [Related]  

  • 58. Pulmonary hypoplasia and osteogenesis imperfecta type II with defective synthesis of alpha I(1) procollagen.
    Shapiro JR; Burn VE; Chipman SD; Jacobs JB; Schloo B; Reid L; Larsen N; Louis F
    Bone; 1989; 10(3):165-71. PubMed ID: 2803853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lethal osteogenesis imperfecta associated with 46,XY,inv(7)(p13q22) karyotype.
    Knisely AS; Richardson A; Abuelo D; Casey S; Singer DB
    J Med Genet; 1988 May; 25(5):352-5. PubMed ID: 3385745
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of a high frequency RsaI polymorphism in the human pro alpha 2(I) collagen gene which is linked to an autosomal dominant form of osteogenesis imperfecta.
    Grobler-Rabie AF; Wallis G; Brebner DK; Beighton P; Bester AJ; Mathew CG
    EMBO J; 1985 Jul; 4(7):1745-8. PubMed ID: 2992938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.